Australia rescinds ban on exports of cannabis. MPX, MYMMF, Solaris and others to benefit.
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) announced that Australia will reverse its ban on cannabis exports, and begin in February 2018 to allow worldwide export of cannabis treatments including oils, patches, sprays, lozenges, and tablets.
Australia’s Health Minister Greg Hunt said, “We would like to be, potentially, the world’s number one medicinal cannabis supplier. One of the conditions of any license for export is that medicinal cannabis is made available to Australian patients first. The sector is fully supportive of that. Australian patients come first. There are now no real government barriers at all to accessing medicinal cannabis.”
This is also good news for MYM Nutraceuticals Inc. (CSE:MYM) (OTC: MYMMF) which has an Australian joint venture, Solaris Nutraceuticals, currently in the licensing process. It is planning to build a 1.2 million-square-foot greenhouse, set to be the largest cannabis production facility in Australia. MYM expects cannabis exports from Australia could outstrip domestic sales.
MYM is constructing two production projects in Québec with over 1.5 million sqft of production space. It is acquiring licenses and is looking to buy complementary businesses in the technology, nutraceuticals and CBD sectors.
Another company that could benefit from the new policy is Solaris Nutraceuticals, headquartered in Sydney, Australia. It is planning to build a 1.2 million sqft greenhouse for cannabis production and medical research in the Northern Rivers Region of New South Wales, Australia.
Solaris aims to deliver sun-grown medical cannabis and to develop medicines for pain management and other conditions.
Source MPX press release
Australia rescinds ban on exports of cannabis. MPX, MYMMF, Solaris and others to benefit.
About Cannin Investment Group: Your Pot Stocks Experts
Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in pot stocks? No! This is the perfect time to invest.
Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.
Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?
Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best pot stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks 2020
